Exploring Nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2 (2025)
- Authors:
- USP affiliated authors: MONTANARI, CARLOS ALBERTO - IQSC ; MARTINS, FELIPE CARDOSO PRADO - IQSC ; ROCHO, FERNANDA DOS REIS - IQSC ; BONATTO, VINÍCIUS - IQSC
- Unidade: IQSC
- DOI: 10.1002/ardp.70158
- Subjects: ENZIMAS; COVID-19
- Keywords: Cysteine protease; Mpro inhibition; SARS-CoV-2; Structure–activity relationships
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Archiv der Pharmazie
- ISSN: 1521-4184
- Volume/Número/Paginação/Ano: v. 358, p. e70158, 2025
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
MARTINS, Felipe Cardoso Prado et al. Exploring Nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2. Archiv der Pharmazie, v. 358, p. e70158, 2025Tradução . . Disponível em: https://doi.org/10.1002/ardp.70158. Acesso em: 04 dez. 2025. -
APA
Martins, F. C. P., Lang, J., Rocho, F. dos R., Wang, X., Bonatto, V., Lameira, J., et al. (2025). Exploring Nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2. Archiv der Pharmazie, 358, e70158. doi:10.1002/ardp.70158 -
NLM
Martins FCP, Lang J, Rocho F dos R, Wang X, Bonatto V, Lameira J, Klein C, Montanari CA. Exploring Nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2 [Internet]. Archiv der Pharmazie. 2025 ; 358 e70158.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1002/ardp.70158 -
Vancouver
Martins FCP, Lang J, Rocho F dos R, Wang X, Bonatto V, Lameira J, Klein C, Montanari CA. Exploring Nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2 [Internet]. Archiv der Pharmazie. 2025 ; 358 e70158.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1002/ardp.70158 - Novel selective proline-based peptidomimetics for human cathepsin K inhibition
- A new strategy to model the mechanism of action of covalent inhibitors
- Synthesis of novel cysteine protease inhibitors and anti-Trypanosoma cruzi agents
- Evaluating the protonation state of the catalytic Cys25 in cruzain cysteine protease: A target for Chagas disease
- Design, synthesis and stepwise optimization of nitrile-based inhibitors of cathepsins B and L
- Predicting the Relative Binding Affinity for Reversible Covalent Inhibitors by Free Energy Perturbation Calculations
- Predicting the affinity of halogenated reversible covalent inhibitors through relative binding free energy
- Nitriles: an attractive approach to the development of covalent inhibitors
- A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021)
- Predicting the ΔΔGbind of halogenated reversible covalent inhibitors of hCatL through computer simulation
Informações sobre o DOI: 10.1002/ardp.70158 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
P22656.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
